Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 1998

View Archived Issues

Company Profile: Cell Genesys

Antidepressant properties of flibanserin may involve dopamine D2/D3 receptors

Genetronics announces end of year summary

Interneuron: Q1 1998 highlights

PKC inhibitors described by Lilly

Abbott reveals new motilides

Novel NK1 antagonists described by Merck & Co.

Progen: Annual Report 1997

Maxamine progresses to phase III in AML

Chloride channel blockers useful for sickle cell anemia

Ganaxolone demonstrates efficacy in phase II migraine trial

Pharmacia & Upjohn develops new antiproliferative agents

SKB evaluates RF-1 as antibacterial target

Nucleoside analogues from BioChem Therapeutic show potential for HIV/AIDS

Rifaximin receives orphan drug status in hepatic encephalopathy

First phase II results reported for EuroAlliance's DAAID

Patent coverage for Idec's humanized antibody for SLE

Idec RSV antibodies covered by U.S. patents; development partners sought

In vitro study shows COX-1/COX-2 inhibition not associated with anticancer activity

HFE: a new therapeutic target for iron overload disorders and cancer

Controlled trial of peptide T for cognitive impairment in HIV-infected patients

TAU-284 awaiting approval in Japan

Clinical status of CS-834

Encouraging results obtained with Hycamtin in multiple myeloma

Cor Therapeutics receives milestone for Integrilin MAA review

Reduction in brain damage with YM-872 in cat model of focal cerebral ischemia

Excellent anxiolytic/side effect profile described for LY-354740

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...